Literature DB >> 33296068

Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis.

Roohollah Mohseni1, Seyed Moayed Alavian1, Zahra Arab Sadeghabadi2, Mohammad Heiat3.   

Abstract

This study was conducted to present the mechanism of the therapeutic effects of Chlorella vulgaris extract (CV) on the carbon tetrachloride (CCl4) induced liver fibrosis model. Primarily, the mechanism of antioxidant effects of CV were investigated via measuring the expression of forkhead box protein O1 (FOXO1) and phosphorylated 5' adenosine monophosphate-activated protein kinase (p-AMPK) as upstream regulators of superoxide dismutase (SOD) and catalase (CAT). Subsequently, we investigated the regulatory effect of CV treatment on the yes-associated protein (YAP) and transcriptional coactivators with a PDZ-binding motif (TAZ) as fibrogenic factors. Male Wistar rats received CCl4 and olive oil solution 1 ml/kg intraperitoneally for 12 weeks, twice weekly. CV 50 and 100 mg/kg were administered on a daily basis by gavage in the last 4 weeks. Ultimately, liver marker enzymes and hepatic hydroxyproline content were measured. The activity of SOD and CAT and the expression of YAP, TAZ, FOXO1, SOD, and CAT were analyzed. Finally, the protein levels of YAP, TAZ, and p-AMPK were detected. CV administration decreased liver marker enzymes and hydroxyproline content significantly. The expression and protein levels of YAP and TAZ reduced by CV treatment. Furthermore, the augmentation of expression and function of CAT and SOD by CV treatment was followed by an increase in the expression of FOXO1 and protein level of p-AMPK. Our data revealed that the stimulation of expression and function of SOD and CAT by CV treatment could be mediated by FOXO1/p-AMPK axis. Moreover, anti-fibrotic effect of CV might be associated with its inhibitory effect on the hepatic expression of YAP and TAZ. Chlorella vulgaris treatment ameliorates liver fibrosis via two cellular mechanisms. A) Likely, Chlorella vulgaris treatment increases gene expression of enzymatic antioxidants superoxide dismutase (SOD) and catalase (CAT) via upregulating its upstream regulatory elements i.e. phosphorylated 5' adenosine monophosphate-activated protein kinase (p-AMPK) and forkhead box protein O1 (FOXO1). These possible regulatory effects maybe lead to reduce reactive oxygen species level (ROS). B) Chlorella vulgaris treatment decreases hepatic protein level and gene expression of key elements of Hippo signaling pathway i.e. Yes-associated protein (YAP) and Transcriptional coactivators with a PDZ-binding motif (TAZ). Figure created with BioRender ( https://biorender.com ). ROS: Reactive oxygen species, YAP: Yes-associated protein, TAZ: Transcriptional coactivators with a PDZ-binding motif, FOXO1: Fork head Box O1, AMPK: 5' adenosine monophosphate activated protein kinase, SOD: Superoxide dismutase, CAT: Catalase, P: Phosphate group.

Entities:  

Keywords:  Carbon tetrachloride; Chlorella vulgaris; Hepatic fibrosis; Transcriptional coactivators with a PDZ-binding motif; Yes-associated protein

Mesh:

Substances:

Year:  2020        PMID: 33296068     DOI: 10.1007/s11033-020-05978-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

Review 1.  Mechanisms of carbon tetrachloride hepatotoxicity.

Authors:  G A Clawson
Journal:  Pathol Immunopathol Res       Date:  1989

2.  The Hippo pathway effector YAP controls mouse hepatic stellate cell activation.

Authors:  Inge Mannaerts; Sofia Batista Leite; Stefaan Verhulst; Sofie Claerhout; Nathalie Eysackers; Lien F R Thoen; Anne Hoorens; Hendrik Reynaert; Georg Halder; Leo A van Grunsven
Journal:  J Hepatol       Date:  2015-04-20       Impact factor: 25.083

3.  Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Xiaobo Wang; Ze Zheng; Jorge Matias Caviglia; Kathleen E Corey; Tina M Herfel; Bishuang Cai; Ricard Masia; Raymond T Chung; Jay H Lefkowitch; Robert F Schwabe; Ira Tabas
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

Review 4.  Burden of liver diseases in the world.

Authors:  Sumeet K Asrani; Harshad Devarbhavi; John Eaton; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-09-26       Impact factor: 25.083

5.  Palmitate-induced IL6 expression ameliorated by chicoric acid through AMPK and SIRT1-mediated pathway in the PBMCs of newly diagnosed type 2 diabetes patients and healthy subjects.

Authors:  Zahra Arab Sadeghabadi; Nasrin Ziamajidi; Roghayeh Abbasalipourkabir; Roohollah Mohseni; Shiva Borzouei
Journal:  Cytokine       Date:  2019-01-25       Impact factor: 3.861

6.  AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.

Authors:  Yu Li; Shanqin Xu; Maria M Mihaylova; Bin Zheng; Xiuyun Hou; Bingbing Jiang; Ogyi Park; Zhijun Luo; Etienne Lefai; John Y-J Shyy; Bin Gao; Michel Wierzbicki; Tony J Verbeuren; Reuben J Shaw; Richard A Cohen; Mengwei Zang
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

Review 7.  Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

Authors:  Joachim H Ix; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

8.  Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl4)-induced liver fibrosis in rats.

Authors:  Roohollah Mohseni; Jamshid Karimi; Heidar Tavilani; Iraj Khodadadi; Mohammad Hashemnia
Journal:  Immunopharmacol Immunotoxicol       Date:  2019-02-01       Impact factor: 2.730

Review 9.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.

Authors:  Fengyun Xu; Changwei Liu; Dandan Zhou; Lei Zhang
Journal:  J Histochem Cytochem       Date:  2016-01-08       Impact factor: 2.479

Review 10.  Pathological mechanisms in carbon tetrachloride hepatotoxicity.

Authors:  W J Brattin; E A Glende; R O Recknagel
Journal:  J Free Radic Biol Med       Date:  1985
View more
  1 in total

1.  Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration.

Authors:  Jianbo Qing; Wenzhu Song; Lingling Tian; Sonia Biju Samuel; Yafeng Li
Journal:  Biomed Res Int       Date:  2022-04-23       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.